BAXTER INTERNATIONAL INC

For the period ended Sep 30, 2026. Filed Oct 29, 2026.

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Sep 30, 2026 · Filed Oct 29, 2026

BAX$26.41+2.4%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Condensed Consolidated Statements of Changes in Equity

Condensed Consolidated Statements of Changes in Equity (unaudited)

	For the three months ended September 30, 2026
	Baxter International Inc. stockholders' equity
	Common stock shares	Common stock	Common stock sharesin treasury	Common stock intreasury	Additional contributed capital	Retained earnings	Accumulated other comprehensiveincome (loss)	Total Baxter stockholders' equity	Noncontrolling interests	Total equity
Balance as of July 1, 2026	683	$683	166	$(10,705)	$6,241	$13,806	$(3,819)	$6,206	$(27)	$6,179
Net income (loss)	—	—	—	—	—	294	—	294	—	294
Other comprehensive income (loss)	—	—	—	—	—	—	(26)	(26)	—	(26)
Stock issued under employee benefit plans and other	—	—	—	20	13	—	—	33	—	33
Dividends declared on common stock	—	—	—	—	—	(5)	—	(5)	—	(5)
Balance as of September 30, 2026	683	$683	166	$(10,685)	$6,254	$14,095	$(3,845)	$6,502	$(27)	$6,475

	For the nine months ended September 30, 2026
	Baxter International Inc. stockholders' equity
	Common stock shares	Common stock	Common stock shares in treasury	Common stock in treasury	Additional contributed capital	Retained earnings	Accumulated other comprehensive income (loss)	Total Baxter stockholders' equity	Noncontrolling interests	Total equity
Balance as of January 1, 2026	683	$683	169	$(10,873)	$6,368	$13,705	$(3,754)	$6,129	$(27)	$6,102
Net income (loss)	—	—	—	—	—	405	—	405	—	405
Other comprehensive income (loss)	—	—	—	—	—	—	(91)	(91)	—	(91)
Stock issued under employee benefit plans and other	—	—	(3)	188	(114)	—	—	74	—	74
Dividends declared on common stock	—	—	—	—	—	(15)	—	(15)	—	(15)
Balance as of September 30, 2026	683	$683	166	$(10,685)	$6,254	$14,095	$(3,845)	$6,502	$(27)	$6,475

	For the three months ended September 30, 2025
	Baxter International Inc. stockholders' equity
Common stock shares · Common stock · Common stock shares in treasury · Common stock in treasury · Additional contributed capital · Retained earnings · Accumulated other comprehensive income (loss) · Total Baxter stockholders' equity · Noncontrolling interests · Total equity
Balance as of July 1, 2025	683	$683	170	$(10,915)	$6,328		$14,970		$(3,746)		$7,320		$(27)		$7,293
Net income (loss)	—	—	—	—	—	(46)		—		(46)		—		(46)
Other comprehensive income (loss)	—	—	—	—	—		—		13		13		—		13
Stock issued under employee benefit plans and other	—	—	—	24	17		—		—		41		—		41
Dividends declared on common stock	—	—	—	—	—		(87)		—	(87)		—		(87)
Balance as of September 30, 2025	683	$683	170	$(10,891)	$6,345		$14,837		$(3,733)		$7,241		$(27)		$7,214

	For the nine months ended September 30, 2025
	Baxter International Inc. stockholders' equity
	Common stock shares	Common stock	Common stock shares in treasury	Common stock in treasury	Additional contributed capital	Retained earnings	Accumulated other comprehensive income (loss)	Total Baxter stockholders' equity	Noncontrolling interests	Total equity
Balance as of January 1, 2025	683	$683	173	$(11,059)	$6,421	$14,929	$(4,010)	$6,964	$60	$7,024
Net income (loss)	—	—	—	—	—	171	—	171	—	171
Other comprehensive income (loss)	—	—	—	—	—	—	162	162	—	162
Reclassification of other comprehensive income (loss) disposed in the Kidney Care Separation	—	—	—	—	—	—	115	115	—	115
Stock issued under employee benefit plans and other	—	—	(3)	168	(76)	—	—	92	—	92
Dividends declared on common stock	—	—	—	—	—	(263)	—	(263)	—	(263)
Disposition of noncontrolling interest associated with the Kidney Care separation	—	—	—	—	—	—	—	—	(87)	(87)
Balance as of September 30, 2025	683	$683	170	$(10,891)	$6,345	$14,837	$(3,733)	$7,241	$(27)	$7,214

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.